We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M Turnover 32.67%
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$694M
AUM Growth
+$30.1M
Cap. Flow
-$11.7M
Cap. Flow %
-1.69%
Top 10 Hldgs %
13.15%
Holding
138
New
29
Increased
10
Reduced
78
Closed
21
Avg Time Held
0.6 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Technology 26.95%
2 Healthcare 21.76%
3 Consumer Discretionary 14.33%
4 Industrials 14.08%
5 Financials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UNFI icon
126
United Natural Foods
UNFI
$2.88B
– –
-93,668
Closed -$7.22M –
URBN icon
127
Urban Outfitters
URBN
$7.42B
– –
-15,170
Closed -$693K –
FNHC
128
DELISTED
FedNat Holding Company Common Stock
FNHC
– –
-194,523
Closed -$5.95M –
SQBG
129
DELISTED
Sequential Brands Group, Inc.
SQBG
– –
-5,695
Closed -$2.44M –
GRUB
130
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-76,927
Closed -$6.98M –
MLNX
131
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-140,235
Closed -$6.36M –
NVDQ icon
132
DELISTED
Novadaq Technologies Inc.
NVDQ
– –
-370,989
Closed -$6.03M –
EVDY
133
DELISTED
Everyday Health, Inc.
EVDY
– –
-218,791
Closed -$2.81M –
SWI icon
134
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
– –
-135,847
Closed -$6.96M –
IGTE
135
DELISTED
IGATE CORPORATION
IGTE
– –
-162,058
Closed -$6.91M –
GEVA
136
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-61,028
Closed -$5.95M –
ABAX
137
DELISTED
Abaxis Inc
ABAX
– –
-119,556
Closed -$7.67M –

Similar funds

Pier Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Pier Capital held 138 positions worth $694M, up 4.5% from $664M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Pier Capital's Q2 2015 filing shows 29 new, 10 increased, 78 reduced and 21 closed positions. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 110,288 shares worth $6.65M. The largest sale was Stagwell, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Pier Capital's largest Q2 2015 buy was Spark Therapeutics, Inc. Common Stock: 110,288 shares worth $6.65M.
  • Pier Capital added most to iShares Russell 2000 Growth ETF in Q2 2015, an estimated $9.68M increase.
  • Pier Capital's biggest Q2 2015 reduction was Marcus & Millichap, cutting an estimated $6.11M.
  • Pier Capital fully exited Stagwell in Q2 2015, selling an estimated $10.1M.
  • Pier Capital's ten largest holdings make up 13% of its $694M portfolio in Q2 2015.
  • Pier Capital opened 29 new positions and closed 21 in Q2 2015.
  • Pier Capital's portfolio value rose 4.5% quarter-over-quarter to $694M.

Based on Pier Capital's 13F filing for Q2 2015, filed 12 Aug 2015.